相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Distinct Phases of Blood Gene Expression Pattern Through Tuberculosis Treatment Reflect Modulation of the Humoral Immune Response
Jacqueline M. Cliff et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Elucidating Novel Serum Biomarkers Associated with Pulmonary Tuberculosis Treatment
Mary A. De Groote et al.
PLOS ONE (2013)
Strain specific transcriptional response in Mycobacterium tuberculosis infected macrophages
Mi-Sun Koo et al.
CELL COMMUNICATION AND SIGNALING (2012)
Host Cell Autophagy Activated by Antibiotics Is Required for Their Effective Antimycobacterial Drug Action
Jwa-Jin Kim et al.
CELL HOST & MICROBE (2012)
The chemotherapy of tuberculosis: past, present and future
D. Mitchison et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2012)
Mycobacterium tuberculosis Modulates Macrophage Lipid-Sensing Nuclear Receptors PPARγ and TR4 for Survival
Sahil Mahajan et al.
JOURNAL OF IMMUNOLOGY (2012)
Tuberculosis Diagnostics and Biomarkers: Needs, Challenges, Recent Advances, and Opportunities
Ruth McNerney et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Modulation of the Cytokine Response in Human Monocytes by Mycobacterium leprae Phenolic Glycolipid-1
Claudia Manca et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2012)
Effect of Standard Tuberculosis Treatment on Plasma Cytokine Levels in Patients with Active Pulmonary Tuberculosis
Catherine Riou et al.
PLOS ONE (2012)
Pyrazinamide pharmacokinetics and efficacy in adults and children
P. R. Donald et al.
TUBERCULOSIS (2012)
Tuberculosis Biomarker and Surrogate Endpoint Research Roadmap
Payam Nahid et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Dose-Dependent Activity of Pyrazinamide in Animal Models of Intracellular and Extracellular Tuberculosis Infections
Zahoor Ahmad et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Phosphodiesterase 4 Inhibition Reduces Innate Immunity and Improves Isoniazid Clearance of Mycobacterium tuberculosis in the Lungs of Infected Mice
Mi-Sun Koo et al.
PLOS ONE (2011)
Phosphodiesterase-4 Inhibition Alters Gene Expression and Improves Isoniazid - Mediated Clearance of Mycobacterium tuberculosis in Rabbit Lungs
Selvakumar Subbian et al.
PLOS PATHOGENS (2011)
Immunological biomarkers of tuberculosis
Gerhard Walzl et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Mycobacterium leprae Actively Modulates the Cytokine Response in Naive Human Monocytes
Daniel Sinsimer et al.
INFECTION AND IMMUNITY (2010)
Mycobacterium tuberculosis Activates Human Macrophage Peroxisome Proliferator-Activated Receptor γ Linking Mannose Receptor Recognition to Regulation of Immune Responses
Murugesan V. S. Rajaram et al.
JOURNAL OF IMMUNOLOGY (2010)
Tuberculosis 4 Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice
Robert S. Wallis et al.
LANCET (2010)
Therapeutic Drug Monitoring for Slow Response to Tuberculosis Treatment in a State Control Program, Virginia, USA
Scott K. Heysell et al.
EMERGING INFECTIOUS DISEASES (2010)
Shortening Treatment in Adults with Noncavitary Tuberculosis and 2-Month Culture Conversion
John L. Johnson et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Paradoxical Effect of Isoniazid on the Activity of Rifampin-Pyrazinamide Combination in a Mouse Model of Tuberculosis
Deepak Almeida et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
The Antituberculosis Drug Pyrazinamide Affects the Course of Cutaneous Leishmaniasis In Vivo and Increases Activation of Macrophages and Dendritic Cells
Susana Mendez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Differential cytokine secretion and early treatment response in patients with pulmonary tuberculosis
J. F. Djoba Siawaya et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
Cyclic AMP - Master regulator of innate immune cell function
Carlos H. Serezani et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2008)
The phenolic glycolipid of Mycobacterium tuberculosis differentially modulates the early host cytokine response but does not in itself confer hypervirulence
Daniel Sinsimer et al.
INFECTION AND IMMUNITY (2008)
Biomarkers for TB treatment response: Challenges and future strategies
Gerhard Walzl et al.
JOURNAL OF INFECTION (2008)
Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1β production
Tatsuya Saitoh et al.
NATURE (2008)
Synergistic activity of R207910 combined with pyrazinamide against murine tuberculosis
M. Ibrahim et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Time to sputum culture conversion in multidrug-resistant tuberculosis: Predictors and relationship to treatment outcome
TH Holtz et al.
ANNALS OF INTERNAL MEDICINE (2006)
Rifampin augments cytokine-induced nitric oxide production in human alveolar epithelial cells
Y Yuhas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Immunomodulating activity of rifampicin
HM Ziglam et al.
JOURNAL OF CHEMOTHERAPY (2004)
Role of peroxisome proliferator-activated receptors in inflammation control
J Youssef et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2004)
PPAR- and LXR-dependent pathways controlling lipid metabolism and the development of atherosclerosis
AC Li et al.
JOURNAL OF LIPID RESEARCH (2004)
Anti-inflammatory effects of moxifloxacin on activated human monocytic cells: Inhibition of NF-KB and mitogen-activated protein kinase activation and of synthesis of proinflammatory ctokines
T Weiss et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Modulation of macrophage apoptosis by antimycobacterial therapy:: physiological role of apoptosis in the control of Mycobacterium tuberculosis
D Gil et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2003)
Immunomodulatory effects of quinolones
A Dalhoff et al.
LANCET INFECTIOUS DISEASES (2003)
Nicotinamide is a potent inhibitor of proinflammatory cytokines
JS Ungerstedt et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2003)
Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid
Y Zhang et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Immunomodulatory and protective effects of moxifloxacin against Candida albicans-induced bronchopneumonia in mice injected with cyclophosphamide
I Shalit et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Nonsteroidal anti-inflammatory drugs induce apoptosis in association with activation of peroxisome proliferator-activated receptor γ in rheumatoid synovial cells
R Yamazaki et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Effect of moxifloxacin on secretion of cytokines by human monocytes stimulated with lipopolysaccharide
FG Araujo et al.
CLINICAL MICROBIOLOGY AND INFECTION (2002)
Potential of rifamides to inhibit TNF-induced NF-kappa B activation
AA Pahlevan et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Effects of amoxicillin on the expression of cytokines during experimental acute otitis media caused by non-typeable Haemophilus influenzae
Å Melhus
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
Peroxisome proliferator-activated receptors in inflammation control
P Delerive et al.
JOURNAL OF ENDOCRINOLOGY (2001)
Peroxisome proliferator-activated receptors (PPARs): Nuclear receptors at the crossroads between lipid metabolism and inflammation
G Chinetti et al.
INFLAMMATION RESEARCH (2000)
Immunosuppressive and anti-inflammatory effects of cyclic AMP phosphodiesterase (PDE) type 4 inhibitors
JE Souness et al.
IMMUNOPHARMACOLOGY (2000)